JOSEPHINE DESERIO: Open Payments
NPI 1780125237 · HARRINGTON PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 12 payments from 7 companies in 2025. Trend: 2023 $118 · 2024 $257 · 2025 $223
Food & beverage: $193Long term medical supply or device loan: $30
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $106 |
| Abbott Laboratories | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Rybelsus, Wegovy, FREESTYLE INSULINX, CAPLYTA, SKYRIZI, Ozempic, REXULTI, INGREZZA.
Industry payments across NJ — which companies pay providers there.
